HEATHER TARNO: Open Payments
NPI 1154007888 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$993 in 40 payments from 12 companies in 2025. Trend: 2023 $283 · 2024 $822 · 2025 $993
Food & beverage: $961Education: $32
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $243 |
| AstraZeneca Pharmaceuticals LP | 3 | $201 |
| ABBVIE INC. | 10 | $145 |
| Lilly USA, LLC | 5 | $110 |
| Novo Nordisk Inc | 3 | $64 |
| Exact Sciences Corporation | 3 | $62 |
| Alnylam Pharmaceuticals Inc. | 2 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| PFIZER INC. | 1 | $22 |
Products named: REPATHA, BREZTRI, OTEZLA, VRAYLAR, MOUNJARO, FARXIGA, GIVLAARI, UBRELVY.
Industry payments across FL — which companies pay providers there.
